Hezong Science&Technology Co Current Liabilities
The Current Liabilities of Hezong Science&Technology Co (300477.SZ) as of Oct 8, 2026 is 1.40 B CNY. In the previous year, Current Liabilities was 4.75 B CNY — a change of -70.45% (lower).
Get this data via API
Financial Data API
Current Liabilities
1.40 BCNY
YoY
-70.45%
Last updated:
The Hezong Science&Technology Co Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 1.40 BCNY | -70.45% | |
| 4.75 BCNY | -15.27% | |
| 5.61 BCNY | +77.36% | |
| 3.16 BCNY | +18.33% | |
| 2.67 BCNY | -0.30% | |
| 2.68 BCNY | +25.51% | |
| 2.14 BCNY | -21.09% | |
| 2.71 BCNY | +37.71% | |
| 1.97 BCNY | +80.80% | |
| 1.09 BCNY | +31.87% | |
| 824.58 MCNY | +44.51% | |
| 570.61 MCNY | +26.31% | |
| 451.74 MCNY | +40.92% | |
| 320.58 MCNY | +53.12% | |
| 209.37 MCNY | +41.18% | |
| 148.30 MCNY | +54.21% | |
| 96.17 MCNY | +50.97% | |
| 63.70 MCNY | +28.68% | |
| 49.50 MCNY | +11.37% | |
| 44.45 MCNY | -7.92% | |
| 48.27 MCNY | — |
Hezong Science&Technology Co Stock analysis
Frequently Asked Questions about Hezong Science&Technology Co stock
Current Liabilities of Hezong Science&Technology Co is 1.40 B CNY in 2025.
Current Liabilities of Hezong Science&Technology Co changed from 4.75 B CNY to 1.40 B CNY, representing a -70.45% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Hezong Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Hezong Science&Technology Co historically and in real time.
Balance Sheet — Hezong Science&Technology Co
All Key Metrics — Hezong Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth